Showing results (1971-1980 of 2,029) with videos related to

Sort By:
Pageof 203
Genome Biology and Evolution|October 19, 2018
Moraxella catarrhalis Restriction-Modification Systems Are Associated with Phylogenetic Lineage and DiseaseLuke V Blakeway, Aimee Tan, Rachael Lappan, et al.
Cancer Research|August 18, 2022
Inhibition of Melanoma Cell-Intrinsic Tim-3 Stimulates MAPK-Dependent TumorigenesisTobias Schatton, Yuta Itoh, Christina Martins, et al.
Clinical Epigenetics|July 30, 2015
Targeted next-generation sequencing reveals high frequency of mutations in epigenetic regulators across treatment-naïve patient melanomasJonathan J Lee, Lynette M Sholl, Neal I Lindeman, et al.
The Journal of Experimental Medicine|October 12, 2020
PD-1 restraint of regulatory T cell suppressive activity is critical for immune toleranceCatherine L Tan, Juhi R Kuchroo, Peter T Sage, et al.
Anesthesiology|December 3, 2019
Transfusion of Uncrossmatched Group O Erythrocyte-containing Products Does Not Interfere with Most ABO TypingsMark H Yazer, Philip C Spinella, Leilani Doyle, et al.
Transfusion|September 9, 2020
Transfusion of blood components containing ABO-incompatible plasma does not lead to higher mortality in civilian trauma patientsJansen N Seheult, Nancy M Dunbar, John R Hess, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 12, 2013
BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanomaDennie T Frederick, Adriano Piris, Alexandria P Cogdill, et al.
The Journal of Investigative Dermatology|September 29, 2022
Hypoxia Controls the Glycome Signature and Galectin-8-Ligand Axis to Promote Protumorigenic Properties of Metastatic MelanomaAsmi Chakraborty, Mariana Perez, Jordan D Carroll, et al.
Cell|September 12, 2015
Melanoma Cell-Intrinsic PD-1 Receptor Functions Promote Tumor GrowthSonja Kleffel, Christian Posch, Steven R Barthel, et al.
Cancer Discovery|February 20, 2014
A small-molecule c-Rel inhibitor reduces alloactivation of T cells without compromising antitumor activityYusuke Shono, Andrea Z Tuckett, Samedy Ouk, et al.
Pageof 203